SCOTT RUDER: Open Payments
NPI 1790733939 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 47 payments from 13 companies in 2025. Trend: 2023 $678 · 2024 $715 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $204 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| Alkermes, Inc. | 4 | $105 |
| Janssen Pharmaceuticals, Inc | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| Noven Therapeutics, LLC | 3 | $60 |
| Lundbeck LLC | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| HARMONY BIOSCIENCES LLC | 1 | $30 |
Products named: VRAYLAR, REXULTI, SPRAVATO, ARISTADA, TRINTELLIX, Xelstrym, AUSTEDO XR, Jornay PM.
Industry payments across TN — which companies pay providers there.
